BFEC
BEAT

Benjamin F. Edwards & Company’s BioTelemetry, Inc. BEAT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-330
Closed -$21K – 1828
2018
Q3 		$21K Buy
+330
New +$18.4K ﹤0.01% 1107

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Benjamin F. Edwards & Company's BEAT Position: Q4 2018 in Review

Benjamin F. Edwards & Company sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 330 shares — an estimated $21K sold.

Benjamin F. Edwards & Company first reported a position in BEAT in Q3 2018 and held it in 1 quarter. The position peaked at $21K in Q3 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Benjamin F. Edwards & Company reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 330 BioTelemetry, Inc. shares in Q4 2018, an estimated $21K.
  • Benjamin F. Edwards & Company first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's BioTelemetry, Inc. position peaked at $21K in Q3 2018.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2018, filed 31 Jan 2019.